Overview This page contains the latest trade data of Unpackaged Medicaments. In 2020, Unpackaged Medicaments were the world's 295th most traded product, with a total trade of $10.6B. Between 2019 and 2020 the exports of Unpackaged Medicaments decreased by -5.27%, from $11.2B to $10.6B. Trade in Unpackaged Medicaments represent 0.064% of total world trade.
Unpackaged Medicaments are a part of Pharmaceutical products. They include Medicaments nes, formulated, in bulk, Antibiotics nes, formulated, in bulk, Hormones nes, no antibiotics, bulk, not contraceptive, Penicillins or streptomycins and derivatives, in bulk, Alkaloids, derivs, without antibiotics, hormones, bul, and Insulin, formulated, in bulk.
Exports In 2020 the top exporters of Unpackaged Medicaments were United States ($1.58B), China ($880M), Germany ($848M), Switzerland ($740M), and Ireland ($739M).
Imports In 2020 the top importers of Unpackaged Medicaments were Ireland ($1.32B), Germany ($947M), United States ($747M), Belgium ($743M), and Netherlands ($585M).
Tariffs In 2018 the average tariff for Unpackaged Medicaments was 3.92%, making it the 1030th lowest tariff using the HS4 product classification.
The countries with the highest import tariffs for Unpackaged Medicaments are Iran (14.9%), Nepal (14.1%), and French Polynesia (13.4%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).
Ranking Unpackaged Medicaments ranks 296th in the Product Complexity Index (PCI).
Description Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.